The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I wouldn’t hold your breath. Would be very surprised to see this return in any meaningful sense. And certainly not anytime soon, when directors have other going concerns to worry about. Always the danger with Shells.
There is nothing you can do - you are locked out of your holding until T212 figure out what to do with it, and it’s not up to them but their intermediary that provide the shares. At best you’ll get the value of your shares back at the last price available before the move to the nas. You will not get Nasdaq shares unless you then repurchase.
To clarify T212 position.
They will sell your holding and credit the account. Shares will not be switched over to NAS. Same as they were going to do with Accustem (should that ever happen).
I appreciate everyone’s enthusiasm for this share and have a very small and very cheap holding myself. However if you understand the politics of the situation you’ll know this has zero chance of being passed any time soon.
No chance tonight but maybe later in the year, depending on next weeks hearing. Will hold as in very low.
I have yet to see the so called 'code 1' ever lead to an RNS the next day. Every one I've come across has yet to do this. Nonsense.
volumes dried up - you're looking at the finish now. Back to pre news levels of movement, just settled a bit higher. Will close 58-62 IMO.
I expect that is our lot for the day. No strong feelings left here. Sellers have taken profits and left, buyers settling in around 62. I was hoping the media blitz would have tickled ÂŁ1. Much longer-term target I guess.
Nolupus - apologies, I've only just seen your message re remapcap etc. Lost in amongst all the others. I'll try and take a look today, but from I already know of that trial, it is an elegant and pragmatic design which should get a lot of juice for the squeeze. Rare to be able to test multiple interventions and perform non-inferiority analysis (which I assume will be their approach). E.g. when testing a new drug/treatment, it is unethical for a placebo group to be given 'no' treatment (for obvious reasons). So in a perfect world the new drug should be trialled alongside the 'best' drug. In the past pharmas have rigged trials by using suboptimal doses of the 'best' drug, terminating trials early etc etc. Much Less prevalent now. Ben Goldacres book 'Bad Pharma' is an excellent primer for all things clinical trial. Anyway, I digress.....
A non-inferiority analysis is set up to show, at the very least, the new compound being trialled is at best equal to the current treatment or treatments. I expect the outcome of the Remacap will be a tiered approach to treatment, with some interventions being tailed to an individuals progression of the disease etc. Long winded spit balling for a Monday morning. I hope some of that makes some sense.
I would expect them to have been carried out in a very rigorous and controlled manner.
What is interesting/moderately amusing to me, are people posting reports of presumably fictional nurses saying 'results look good' or similar by various over excited rampers. Of course, if this were true, all that indicates is a badly run and poorly blinded trial. SO they are in effect, 'deramping' their own share without being switched on enough to realise that. Dozens of examples of this over on the twitters.
Ahhhhh but I have also only posted ~20 times, Which seems to matter to people.
Probably the same people that afford lots of weight to a scientists H-index ;-)
I have taken a pasting on the twitter-sphere for pointing out that reports of success before a trial is over is an indication of a badly run trial. I do not believe this to be the case and expect this will be a rigorously conducted experiment. Ironically, the rampers making such claims of success before the trial is over are actually casting doubt on the experimental rigor and robustness of the trial...
Strictly. Scientist here. And one who has run and assisted on numerous clinical RCTs over many years.
Yes - it is very very very difficult to 'second guess' who has been given which treatment in a double-blind trial. Especially one that is across multiple centers as you of course only have access to the patients within your research center. People with serious medical conditions recover at varying rates and with varying degrees of success. In this case, the people receiving the placebo treatment are still, of course, receiving standard treatment on top of SNG001. The points Phoenix mate is valid. And trial coding is never patient A1, A2, A3, B1, B2, B3, etc so it is not as straightforward as looking at how the people in groups a and b are doing. Achieving successful trial blinding is afforded huge importance in the literature and in the trial design process and ethical application (usually randomization and blinding have their own specific subsections to fill in). SO if, as has been reported on here and on twitter 'nurses are seeing good results' etc etc, that would give me substantial cause for concern regarding the robustness of the trial set up.
In short, blinding will only be broken at the end of the study when results have been analyzed and not before. If facts make me a deramper then fine.
They've gone and moved on to the next from what I can tell. 8p was probably a good short term target for them. Todays ramp seems to be ARE and ARG . Painful and predictable to watch. I hope this recovers.
Careful G-man, sensible and reasoned chat like that will get you marked as a deramper. People only want to hear of rocket and moons remember. A close over ÂŁ1 would be a win IMO, and I'm surprised people expected more from a conference abstract. If it was HUUUUUGEEEE news I would expect the conference to have put them out as keynotes, not poster sessions.
medium-term holder here. Think the placing is already factored into the price or would you be expecting a dip after the AGM?
Nice company and some great products ready to go. Be nice to see this start moving again
115 - 120 more realistic. The early morning spike wasn't as high as I had hoped.
squidge - you only have 10 posts. I have 15. Therefore my opinion is almost 50% more valid than yours ; )
It will be a while yet I think before anything significant lands. I thought I was meant to have been thanking topi last Friday. I guess if he couldn't discover that it was a bank holiday , thus markers shut then his 'research' into a company probably wasn't great either :D
Charlie was pumping the life out of this (second only to Toppi). Odd to suddenly change tune. I hoped for better but looks like this will be a slow burner, which is fine.
Yeah true enough. Hows the volume today vs. the time it was being ramped yesterday though?
Again I hope it does rise, but a 30-40% on open (like one poster suggested), or back to over 10p today doesn't strike me as realistic. I hope I am wrong.
Not all no. But there are plenty of newcomers that seem to be taken in by various rampers on twitter for example. Hence yesterday's very quick rise and fall. Or do you disagree with that assessment?